To include your compound in the COVID-19 Resource Center, submit it here.

BMY down on formal SEC probe

Bristol-Myers (BMY) was off $0.77 to $24.29 on 8.1 million shares on Thursday after disclosing

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE